<VariationArchive VariationID="42632" VariationName="NM_000256.3(MYBPC3):c.2524dup (p.Tyr842fs)" VariationType="Duplication" Accession="VCV000042632" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-14" DateCreated="2015-01-30" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="51802" VariationID="42632">
      <GeneList>
        <Gene Symbol="MYBPC3" FullName="myosin binding protein C3" GeneID="4607" HGNC_ID="HGNC:7551" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47331406" stop="47352702" display_start="47331406" display_stop="47352702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47352956" stop="47374252" display_start="47352956" display_stop="47374252" Strand="-" />
          </Location>
          <OMIM>600958</OMIM>
          <Haploinsufficiency last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000256.3(MYBPC3):c.2524dup (p.Tyr842fs)</Name>
      <CanonicalSPDI>NC_000011.10:47337468:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47337468" stop="47337469" display_start="47337468" display_stop="47337469" variantLength="1" positionVCF="47337468" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47359019" stop="47359020" display_start="47359019" display_stop="47359020" variantLength="1" positionVCF="47359019" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <OtherNameList>
        <Name>p.Tyr842LeufsX42</Name>
      </OtherNameList>
      <ProteinChange>Y842fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_386" sequenceAccession="LRG_386">
            <Expression>LRG_386:g.20234dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.47337469dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.47337469dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.47359020dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.47359020dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007667.1" sequenceAccession="NG_007667" sequenceVersion="1" change="g.20234dup">
            <Expression>NG_007667.1:g.20234dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000256.3" sequenceAccession="NM_000256" sequenceVersion="3" change="c.2524dup" MANESelect="true">
            <Expression>NM_000256.3:c.2524dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000247.2" sequenceAccession="NP_000247" sequenceVersion="2" change="p.Tyr842fs">
            <Expression>NP_000247.2:p.Tyr842fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_386t1" sequenceAccession="LRG_386t1">
            <Expression>LRG_386t1:c.2524dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_386p1" sequenceAccession="LRG_386p1" change="p.Tyr842fs">
            <Expression>LRG_386p1:p.Tyr842fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000256.3" sequenceAccession="NM_000256" sequenceVersion="3" change="c.2524dupT" MANESelect="true">
            <Expression>NM_000256.3:c.2524dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA012465" DB="ClinGen" />
        <XRef Type="rs" ID="397515970" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.2524dup (p.Tyr842fs) AND Hypertrophic cardiomyopathy" Accession="RCV000035500" Version="7">
        <ClassifiedConditionList TraitSetID="17368">
          <ClassifiedCondition DB="MedGen" ID="C0007194">Hypertrophic cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-09-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.2524dup (p.Tyr842fs) AND Hypertrophic cardiomyopathy 1" Accession="RCV000201921" Version="2">
        <ClassifiedConditionList TraitSetID="6411">
          <ClassifiedCondition DB="MedGen" ID="C3495498">Hypertrophic cardiomyopathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-05-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-01-30" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28615295</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23396983</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19574547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27532257</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6411" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1311" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MYH7-Related Familial Hypertrophic Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy 1</ElementValue>
                <XRef ID="MONDO:0008647" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypertrophic cardiomyopathy 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMH1</ElementValue>
                <XRef Type="MIM" ID="192600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="CUI, rejected">C0949658</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hypertrophic cardiomyopathy (HCM) is typically defined by the presence of unexplained left ventricular hypertrophy (LVH). Such LVH occurs in a non-dilated ventricle in the absence of other cardiac or systemic disease capable of producing the observed magnitude of increased LV wall thickness, such as pressure overload (e.g., long-standing hypertension, aortic stenosis) or storage/infiltrative disorders (e.g., Fabry disease, amyloidosis). The clinical manifestations of HCM range from asymptomatic LVH to progressive heart failure to sudden cardiac death (SCD), and vary from individual to individual even within the same family. Common symptoms include shortness of breath (particularly with exertion), chest pain, palpitations, orthostasis, presyncope, and syncope. Most often the LVH of HCM becomes apparent during adolescence or young adulthood, although it may also develop late in life, in infancy, or in childhood.</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301725</ID>
                <ID Source="BookShelf">NBK1768</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21267010</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C3495498" DB="MedGen" />
              <XRef ID="MONDO:0008647" DB="MONDO" />
              <XRef Type="MIM" ID="192600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="17368" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22501" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy</ElementValue>
                <XRef ID="HP:0001639" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005045" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERTROPHIC MYOCARDIOPATHY</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20518" />
                <XRef ID="20518" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="217569" DB="Orphanet" />
              <XRef ID="C0007194" DB="MedGen" />
              <XRef ID="D002312" DB="MeSH" />
              <XRef ID="MONDO:0005045" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001639" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="100350" SubmissionDate="2019-03-21" DateLastUpdated="2015-01-30" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="36512496|Orphanet:ORPHA217569" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000059150" DateUpdated="2015-01-30" DateCreated="2013-05-03" Type="SCV" Version="5" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-05-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Tyr842fs variant has not been reported in the literature nor been previously detected in over 1,600 Caucasian probands tested by our laboratory. This varia nt meets our criteria for pathogenicity (http://pcpgm.partners.org/LMM) based on the following data. This individual?s racial background is reported to be Cauca sian and the low frequency of this variant in this population supports a pathoge nic role. In addition, the variant is predicted to cause a frameshift, which al ters the protein's amino acid sequence beginning at codon 842 and leads to a pre mature stop codon 42 amino acids downstream. This alteration is then predicted t o lead to a truncated or absent protein (loss of function). Loss of function of the MYBPC3 gene is an established disease mechanism for HCM, which strongly supp orts a pathogenic role of the Tyr842fs variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000256.3:EXON 25</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000256.3:c.2524dupT</Name>
            <Name>p.Tyr842LeufsX42</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.47359019_47359020insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA217569" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="479114" SubmissionDate="2015-08-25" DateLastUpdated="2015-11-14" DateCreated="2015-11-14">
        <ClinVarSubmissionID localKey="VAR0000081|OMIM:192600" />
        <ClinVarAccession Accession="SCV000256647" DateUpdated="2015-11-14" DateCreated="2015-11-14" Type="SCV" Version="2" SubmitterName="Agnes Ginges Centre for Molecular Cardiology, Centenary Institute" OrgID="505375" OrganizationCategory="laboratory" OrgAbbreviation="CI-AGCMC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MYBPC3 Tyr842fs variant is absent from the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/). We have identified this variant in 1 HCM proband (IVS 24mm). This MYBPC3 insertion variant (c.2525dupT) is predicted to interrupt the reading frame and lead to a premature stop codon, and a truncated or absent protein. Loss-of-function mutations in the MYBPC3 gene are an established mechanism of disease in HCM hence, we classify MYBPC3 Tyr842fs as "pathogenic".</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Agnes Ginges Centre for Molecular Cardiology criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/uci8jhha/mdi-5363_505375_agnesginges_variantassess_clinvar.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.2524dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192600" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6130071" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4894475|MedGen:C0007194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003439700" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23396983</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27532257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28615295</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19574547</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 42632). This premature translational stop signal has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 23396983, 27532257, 28615295). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr842Leufs*42) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.47359019_47359020insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0007194" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6130071" TraitType="Disease" MappingType="XRef" MappingValue="C0007194" MappingRef="MedGen">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="479114" TraitType="Disease" MappingType="XRef" MappingValue="192600" MappingRef="OMIM">
        <MedGen CUI="C3495498" Name="Hypertrophic cardiomyopathy 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="100350" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA217569" MappingRef="Orphanet">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

